ELEVATED SERUM FERRITIN IS ASSOCIATED WITH CIRRHOSIS-PROMOTING GENETIC VARIANTS BUT NOT WITH HFE MUTATIONS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

被引：0
|
作者：
Suresh, Deepika
Krach, Kristin
Chen, Vincent L.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1559
引用
收藏
页码：S1293 / S1294
页数：2
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [42] Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
    Al Hashmi, Khamis
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Patti, Angelo Maria
    Al Waili, Khalid
    Al Rasadi, Khalid
    Ciaccio, Marcello
    Rizzo, Manfredi
    FRONTIERS IN NUTRITION, 2024, 11
  • [43] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [45] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [46] Disease severity assessment of metabolic dysfunction-associated fatty liver disease in Taiwan
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Huang, Ching-I
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Dai, Chia-Yen
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2022, 77 : S458 - S459
  • [47] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [48] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207
  • [49] Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study
    Xie, Cheng-Han
    Chen, Li-Wei
    Lin, Chih-Lang
    Hu, Ching-Chih
    Chien, Cheng-Hung
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [50] Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
    Armandi, Angelo
    Sanavia, Tiziana
    Younes, Ramy
    Caviglia, Gian Paolo
    Rosso, Chiara
    Govaere, Olivier
    Liguori, Antonio
    Francione, Paolo
    Gallego-Duran, Rocio
    Ampuero, Javier
    Pennisi, Grazia
    Aller, Rocio
    Tiniakos, Dina
    Burt, Alastair
    David, Ezio
    Vecchio, Fabio
    Maggioni, Marco
    Cabibi, Daniela
    Mcleod, Duncan
    Pareja, Maria Jesus
    Zaki, Marco Y. W.
    Stal, Per
    Kechagias, Stergios
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Grieco, Antonio
    Miele, Luca
    Fariselli, Piero
    Eslam, Mohammed
    Petta, Salvatore
    Hagstroem, Hannes
    George, Jacob
    Schattenberg, Joern M.
    Romero-Gomez, Manuel
    Anstee, Quentin Mark
    Bugianesi, Elisabetta
    GUT, 2024, 73 (05) : 825 - 834
12345